3i Infotech Ltd has entered into definitive agreements to sell its software products business to the funds advised by Apax Partners for Rs 1,000 crore
Launch of a cancer drug was delayed due to Covid-19
The company said profitability was impacted on account of higher R&D expenses, staff costs, other expenses and forex losses
Ramp-up and new biosimilars should help boost profit
Analysts expect Biocon to gain 20-25 per cent market share and after factoring in a 20-25 per cent price erosion in the first year, they see its earnings improving to Rs 12-16